NO20052549L - Anvendelse av en PPARalfa-agonist og metformin for redusering av serumtriglycerider. - Google Patents
Anvendelse av en PPARalfa-agonist og metformin for redusering av serumtriglycerider.Info
- Publication number
- NO20052549L NO20052549L NO20052549A NO20052549A NO20052549L NO 20052549 L NO20052549 L NO 20052549L NO 20052549 A NO20052549 A NO 20052549A NO 20052549 A NO20052549 A NO 20052549A NO 20052549 L NO20052549 L NO 20052549L
- Authority
- NO
- Norway
- Prior art keywords
- metformin
- reducing serum
- serum triglycerides
- pparalpha agonist
- agonist
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title abstract 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003105 metformin Drugs 0.000 title abstract 2
- 210000002966 serum Anatomy 0.000 title abstract 2
- 150000003626 triacylglycerols Chemical class 0.000 title abstract 2
- 102000023984 PPAR alpha Human genes 0.000 title 1
- 108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 title 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 abstract 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02292940A EP1424070A1 (en) | 2002-11-28 | 2002-11-28 | Combination of a PPAR alpha agonist and metformin for decreasing the serum triglycerides |
| PCT/EP2003/013302 WO2004047831A2 (en) | 2002-11-28 | 2003-11-26 | Use of a pparalpha agonist and metformin for decreasing the serum triglycerides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20052549L true NO20052549L (no) | 2005-06-10 |
Family
ID=32241358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052549A NO20052549L (no) | 2002-11-28 | 2005-05-26 | Anvendelse av en PPARalfa-agonist og metformin for redusering av serumtriglycerider. |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20060142397A1 (ru) |
| EP (2) | EP1424070A1 (ru) |
| JP (1) | JP2006508995A (ru) |
| CN (1) | CN1777417B (ru) |
| AT (1) | ATE362362T1 (ru) |
| AU (1) | AU2003288175B2 (ru) |
| BR (1) | BR0316810A (ru) |
| CA (1) | CA2507894C (ru) |
| CY (1) | CY1106749T1 (ru) |
| DE (1) | DE60313886T2 (ru) |
| DK (1) | DK1569634T3 (ru) |
| EA (1) | EA009772B1 (ru) |
| ES (1) | ES2287546T3 (ru) |
| HK (1) | HK1077755A1 (ru) |
| MA (1) | MA27553A1 (ru) |
| MX (1) | MXPA05005707A (ru) |
| NO (1) | NO20052549L (ru) |
| PT (1) | PT1569634E (ru) |
| SI (1) | SI1569634T1 (ru) |
| TN (1) | TNSN05148A1 (ru) |
| WO (1) | WO2004047831A2 (ru) |
| ZA (1) | ZA200504345B (ru) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6414002B1 (en) | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| EP1457206A1 (en) * | 2003-03-13 | 2004-09-15 | Fournier Laboratories Ireland Limited | Combined use of a fibrate and orlistat for the treatment of obesity |
| EP1559419A1 (en) * | 2004-01-23 | 2005-08-03 | Fournier Laboratories Ireland Limited | Pharmaceutical formulations comprising metformin and a fibrate, and processes for their obtention |
| FR2896160B1 (fr) * | 2006-01-13 | 2008-04-25 | Merck Sante Soc Par Actions Si | Combinaison de derives de triazine et d'agonistes du ppar alpha. |
| WO2010132580A2 (en) * | 2009-05-12 | 2010-11-18 | The Administrators Of The Tulane Educational Fund | Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| US9724381B2 (en) | 2009-05-12 | 2017-08-08 | The Administrators Of The Tulane Educational Fund | Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| WO2011159917A2 (en) | 2010-06-16 | 2011-12-22 | The Administrators Of The Tulane Educational Fund | Growth hormone secretatogue receptor antagonists and uses thereof |
| FR3050112B1 (fr) * | 2016-04-15 | 2020-09-04 | Soc Civ Immobiliere Gecinq | Utilisation de l'acide fenofibrique dans le traitement des maladies hepatiques |
| CN107496397A (zh) * | 2016-06-14 | 2017-12-22 | 重庆安格龙翔医药科技有限公司 | 一种二甲双胍与非诺贝酸的复合物及其制剂 |
| FR3056908B1 (fr) * | 2016-09-30 | 2019-04-19 | Nashpharm | Sel de metformine et d'elafibranor presentant une activite duale pour le traitement de l'obesite associee a la steato-hepatite non alcoolique (nash) et a l'hypertriglyceridemie |
| CN111374093A (zh) * | 2018-12-28 | 2020-07-07 | 高倩 | 超级肥胖小鼠的构建与鉴定方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT323195B (de) * | 1973-03-16 | 1975-06-25 | Hurka Wilhelm | Verfahren zur herstellung neuer salze von biguaniden |
| FR2275199A1 (fr) * | 1974-06-19 | 1976-01-16 | Cerpha | (chloro-4 phenoxy) isobutyrate de dimethylbiguanide, son procede de preparation et medicaments contenant ce produit comme principe actif |
| US5190970A (en) * | 1990-10-19 | 1993-03-02 | E. R. Squibb & Sons, Inc. | Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor |
| US5739106A (en) * | 1995-06-07 | 1998-04-14 | Rink; Timothy J. | Appetite regulating compositions |
| WO1997027847A1 (en) * | 1996-02-02 | 1997-08-07 | Merck & Co., Inc. | Method of treating diabetes and related disease states |
| EP0930882A2 (en) * | 1996-08-02 | 1999-07-28 | Institut Pasteur De Lille | Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
| FR2774591B1 (fr) * | 1998-02-12 | 2000-05-05 | Lipha | Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie |
| US5942500A (en) * | 1998-04-27 | 1999-08-24 | Perry; Stephen C. | Dietary composition to reduce dietary fats |
| FR2796940B1 (fr) * | 1999-07-26 | 2005-04-08 | Lipha | Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant |
| US6498193B2 (en) * | 1999-12-22 | 2002-12-24 | Trustees Of Dartmouth College | Treatment for complications of type 2 diabetes |
| US6569879B2 (en) * | 2000-02-18 | 2003-05-27 | Merck & Co., Inc. | Aryloxyacetic acids for diabetes and lipid disorders |
| US20030092736A1 (en) * | 2001-05-30 | 2003-05-15 | Cheng Peter T. | Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
| WO2004034968A2 (en) * | 2002-08-20 | 2004-04-29 | The Regents Of The University Of California | Combination therapy for controlling appetites |
-
2002
- 2002-11-28 EP EP02292940A patent/EP1424070A1/en not_active Withdrawn
-
2003
- 2003-11-26 US US10/536,660 patent/US20060142397A1/en not_active Abandoned
- 2003-11-26 EP EP03780062A patent/EP1569634B8/en not_active Expired - Lifetime
- 2003-11-26 AT AT03780062T patent/ATE362362T1/de active
- 2003-11-26 WO PCT/EP2003/013302 patent/WO2004047831A2/en active IP Right Grant
- 2003-11-26 BR BR0316810-7A patent/BR0316810A/pt not_active IP Right Cessation
- 2003-11-26 SI SI200330898T patent/SI1569634T1/sl unknown
- 2003-11-26 CA CA2507894A patent/CA2507894C/en not_active Expired - Fee Related
- 2003-11-26 DE DE60313886T patent/DE60313886T2/de not_active Expired - Lifetime
- 2003-11-26 DK DK03780062T patent/DK1569634T3/da active
- 2003-11-26 PT PT03780062T patent/PT1569634E/pt unknown
- 2003-11-26 MX MXPA05005707A patent/MXPA05005707A/es active IP Right Grant
- 2003-11-26 AU AU2003288175A patent/AU2003288175B2/en not_active Ceased
- 2003-11-26 ES ES03780062T patent/ES2287546T3/es not_active Expired - Lifetime
- 2003-11-26 EA EA200500691A patent/EA009772B1/ru not_active IP Right Cessation
- 2003-11-26 CN CN2003801044454A patent/CN1777417B/zh not_active Expired - Fee Related
- 2003-11-26 JP JP2004554485A patent/JP2006508995A/ja active Pending
-
2005
- 2005-05-26 MA MA28301A patent/MA27553A1/fr unknown
- 2005-05-26 NO NO20052549A patent/NO20052549L/no not_active Application Discontinuation
- 2005-05-27 ZA ZA200504345A patent/ZA200504345B/en unknown
- 2005-05-27 TN TNP2005000148A patent/TNSN05148A1/fr unknown
- 2005-11-08 HK HK05109941A patent/HK1077755A1/xx not_active IP Right Cessation
-
2007
- 2007-07-20 CY CY20071100972T patent/CY1106749T1/el unknown
-
2010
- 2010-02-12 US US12/705,155 patent/US20100144874A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2507894C (en) | 2011-01-04 |
| CA2507894A1 (en) | 2004-06-10 |
| DE60313886T2 (de) | 2008-01-17 |
| MA27553A1 (fr) | 2005-10-03 |
| AU2003288175B2 (en) | 2008-11-13 |
| BR0316810A (pt) | 2005-10-18 |
| ZA200504345B (en) | 2006-08-30 |
| WO2004047831A2 (en) | 2004-06-10 |
| US20060142397A1 (en) | 2006-06-29 |
| US20100144874A1 (en) | 2010-06-10 |
| ES2287546T3 (es) | 2007-12-16 |
| CN1777417A (zh) | 2006-05-24 |
| HK1077755A1 (en) | 2006-02-24 |
| CY1106749T1 (el) | 2012-05-23 |
| WO2004047831A3 (en) | 2005-02-24 |
| MXPA05005707A (es) | 2005-07-26 |
| JP2006508995A (ja) | 2006-03-16 |
| AU2003288175A1 (en) | 2004-06-18 |
| EP1569634A2 (en) | 2005-09-07 |
| PT1569634E (pt) | 2007-08-22 |
| EP1424070A1 (en) | 2004-06-02 |
| SI1569634T1 (sl) | 2007-10-31 |
| TNSN05148A1 (fr) | 2007-05-14 |
| ATE362362T1 (de) | 2007-06-15 |
| EA009772B1 (ru) | 2008-04-28 |
| DE60313886D1 (de) | 2007-06-28 |
| EP1569634B1 (en) | 2007-05-16 |
| DK1569634T3 (da) | 2007-09-10 |
| CN1777417B (zh) | 2010-10-06 |
| EP1569634B8 (en) | 2007-08-29 |
| EA200500691A1 (ru) | 2005-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052549L (no) | Anvendelse av en PPARalfa-agonist og metformin for redusering av serumtriglycerider. | |
| DE60330079D1 (de) | Ölring | |
| NO20051360L (no) | Gjenget rørskjøt | |
| ECSP045220A (es) | Derivados de n-fenil-2-pirimidin-amina | |
| NO20062649L (no) | Biarylsulfonamider og metoder for anvendelse av disse | |
| DK1549872T3 (da) | Gevindskåret rörsamling | |
| NO20043004L (no) | 4-oksokinolin forbindelse og anvendelse derav som HIV-integraseinhibitor | |
| DE60302321D1 (de) | Zusammengesetzter Ölring | |
| PT1481407E (pt) | Transformador | |
| NO20032374L (no) | Ringromsventil for rör | |
| NO20043907L (no) | Partielle og fullstendige agonister av A1-adenosinreseptorer | |
| EA200300925A1 (ru) | Новый способ промышленного синтеза ранелата стронция и его гидратов | |
| DE60213493D1 (de) | Verbesserungen an oder bezüglich Rohrkupplungen | |
| ITMI20021399A1 (it) | Inibitori della cicloossigenasi 2 | |
| NO20040133L (no) | Additiv og anvendelse derav som korrosjonsinhibitor | |
| DK1537091T3 (da) | Hidtil ukendte 2-arylthiazolforbindelser som PPAR alpha- og PPAR gamma-agonister | |
| DE60324418D1 (de) | Nicht-nukleosidische inhibitoren der reversen transkriptase | |
| ITTN20020003A1 (it) | Guarnizione intumescente | |
| EA200401235A1 (ru) | Способ получения модафинила | |
| ATE429214T1 (de) | Mikrokapseln für die verzögerte kontrollierte freisetzung von perindopril | |
| IL163960A0 (en) | Broadspectrum subsituted benzimidazole sulfonamidehiv protease inhibitors | |
| IS7537A (is) | Notkun á nýjum etónógestrel esterum. | |
| DE60331820D1 (de) | Beseitigung von verstopfungen von rohrleitungen | |
| NO20044752L (no) | Sammenstilling av flerkanalsrørledninger | |
| DE10292132D2 (de) | Transportable Toilette |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |